A 14-Year Longitudinal Analysis of Healthcare Expenditure on Dementia and Related Factors (DEMENCOST Study).
Alzheimer’s disease
dementia
health care expenditure
health management organization
real world data
social care expenditure
Journal
Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863
Informations de publication
Date de publication:
2023
2023
Historique:
medline:
5
9
2023
pubmed:
24
7
2023
entrez:
24
7
2023
Statut:
ppublish
Résumé
The large number of dementia cases produces a great pressure on health and social care services, which requires efficient planning to meet the needs of patients through infrastructure, equipment, and financial, technical, and personal resources adjusted to their demands. Dementia analysis requires studies with a very precise patient characterization of both the disease and comorbidities present, and long-term follow-up of patients in clinical aspects and patterns of resource utilization and costs generated. To describe and quantify direct healthcare expenditure and its evolution from three years before and up to ten years after the diagnosis of dementia, compared to a matched group without dementia. Retrospective cohort design with follow-up from 6 to 14 years. We studied 996 people with dementia (PwD) and 2,998 controls matched for age, sex, and comorbidity. This paper adopts the provider's perspective as the perspective of analysis and refers to the costs actually incurred in providing the services. Aggregate costs and components per patient per year were calculated and modelled. Total health expenditure increases in PwD from the year of diagnosis and in each of the following 7 years, but not thereafter. Health status and mortality are factors explaining the evolution of direct costs. Dementia alone is not a statistically significant factor in explaining differences between groups. The incremental direct cost of dementia may not be as high or as long as studies with relatively short follow-up suggest. Dementia would have an impact on increasing disease burden and mortality.
Sections du résumé
BACKGROUND
The large number of dementia cases produces a great pressure on health and social care services, which requires efficient planning to meet the needs of patients through infrastructure, equipment, and financial, technical, and personal resources adjusted to their demands. Dementia analysis requires studies with a very precise patient characterization of both the disease and comorbidities present, and long-term follow-up of patients in clinical aspects and patterns of resource utilization and costs generated.
OBJECTIVE
To describe and quantify direct healthcare expenditure and its evolution from three years before and up to ten years after the diagnosis of dementia, compared to a matched group without dementia.
METHODS
Retrospective cohort design with follow-up from 6 to 14 years. We studied 996 people with dementia (PwD) and 2,998 controls matched for age, sex, and comorbidity. This paper adopts the provider's perspective as the perspective of analysis and refers to the costs actually incurred in providing the services. Aggregate costs and components per patient per year were calculated and modelled.
RESULTS
Total health expenditure increases in PwD from the year of diagnosis and in each of the following 7 years, but not thereafter. Health status and mortality are factors explaining the evolution of direct costs. Dementia alone is not a statistically significant factor in explaining differences between groups.
CONCLUSION
The incremental direct cost of dementia may not be as high or as long as studies with relatively short follow-up suggest. Dementia would have an impact on increasing disease burden and mortality.
Identifiants
pubmed: 37482993
pii: JAD221220
doi: 10.3233/JAD-221220
pmc: PMC10578278
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
131-147Références
Neurology. 2020 Aug 4;95(5):e519-e531
pubmed: 32611641
Health Serv Res. 2012 Aug;47(4):1660-78
pubmed: 22171532
J Am Geriatr Soc. 2021 Jul;69(7):1774-1783
pubmed: 34245588
Health Econ. 2018 May;27(5):865-876
pubmed: 29424031
Eur J Health Econ. 2019 Apr;20(3):333-342
pubmed: 30171490
Rev Neurol. 2012 Apr 1;54(7):399-406
pubmed: 22451126
J Alzheimers Dis. 2017;59(3):997-1007
pubmed: 28697570
Health Syst Transit. 2018 May;20(2):1-179
pubmed: 30277216
BMC Psychiatry. 2014 Mar 20;14:84
pubmed: 24645776
J Alzheimers Dis. 2021;83(1):333-354
pubmed: 34334395
Med Care. 2004 Jan;42(1):81-90
pubmed: 14713742
Eur J Health Econ. 2022 Sep;23(7):1121-1149
pubmed: 35037122
J Alzheimers Dis. 2016 Jul 1;53(4):1341-51
pubmed: 27392854
Alzheimers Dement. 2011 May;7(3):318-27
pubmed: 21575872
Pharmacoeconomics. 2009;27(5):391-403
pubmed: 19586077
Alzheimers Dement. 2019 Jul;15(7):917-926
pubmed: 31175028
Lancet Neurol. 2016 Jan;15(1):116-24
pubmed: 26300044
Int J Geriatr Psychiatry. 2011 Aug;26(8):825-32
pubmed: 21744385
Acta Psychiatr Scand. 2010 Apr;121(4):243-59
pubmed: 19694634
Rev Esp Geriatr Gerontol. 2017 Nov - Dec;52(6):342-347
pubmed: 28336082
Am J Manag Care. 2019 Aug 1;25(8):e247-e253
pubmed: 31419102
J Alzheimers Dis. 2015;43(4):1271-84
pubmed: 25159675
Dementia (London). 2020 Jul;19(5):1426-1440
pubmed: 30231623
Am J Manag Care. 2001 Aug;7(8):809-18
pubmed: 11519239
Int J Integr Care. 2016 Aug 19;16(3):10
pubmed: 28316542
Clin Epidemiol. 2019 Jul 16;11:525-542
pubmed: 31410066
Aten Primaria. 2013 Nov;45(9):461-75
pubmed: 23830042
BMC Neurol. 2009 Jan 28;9:5
pubmed: 19175921
J Alzheimers Dis. 2015;48(3):721-30
pubmed: 26402090
Alzheimers Dement. 2017 Jan;13(1):1-7
pubmed: 27583652
Int Psychogeriatr. 2017 Dec;29(12):2081-2093
pubmed: 28720158
Age Ageing. 2021 May 5;50(3):861-867
pubmed: 33000145
J Alzheimers Dis. 2019;68(2):635-646
pubmed: 30856111
Gac Sanit. 2009 Jan-Feb;23(1):29-37
pubmed: 19231720
Value Health. 2021 Dec;24(12):1863-1870
pubmed: 34838285
BMC Health Serv Res. 2012 Jun 19;12:165
pubmed: 22713212
Rev Neurol. 2010 Aug 16;51(4):201-7
pubmed: 20648463
BMC Geriatr. 2014 Jun 17;14:76
pubmed: 24934556
Lancet Public Health. 2022 Feb;7(2):e105-e125
pubmed: 34998485
Acta Psychiatr Scand. 2011 Nov;124(5):384-95
pubmed: 21838738
BMJ Open. 2020 Aug 7;10(8):e035463
pubmed: 32771987
Dement Geriatr Cogn Disord. 2010;29(6):475-83
pubmed: 20523045
J Alzheimers Dis. 2017;57(1):305-315
pubmed: 28222520
Gac Sanit. 2019 Jan - Feb;33(1):17-23
pubmed: 28807389
Int J Geriatr Psychiatry. 2019 Jul;34(7):1095-1103
pubmed: 30950106
Eur J Health Econ. 2019 Nov;20(8):1207-1236
pubmed: 31342208
Value Health. 2018 Mar;21(3):295-303
pubmed: 29566836
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
Am J Geriatr Psychiatry. 2014 Apr;22(4):381-8
pubmed: 23567428
Alzheimers Dement (N Y). 2021 Sep 14;7(1):e12198
pubmed: 34541291
J Alzheimers Dis. 2015;43(4):1293-302
pubmed: 25159671
Dementia (London). 2020 Nov;19(8):2637-2657
pubmed: 30909718
PLoS One. 2013 Jul 18;8(7):e70018
pubmed: 23875017
Lancet Reg Health Eur. 2022 Jun 24;20:100445
pubmed: 35781926
BMC Health Serv Res. 2013 Oct 25;13:440
pubmed: 24156613
Int J Nurs Stud. 2016 Mar;55:39-49
pubmed: 26632506
Neurology. 1993 Nov;43(11):2412-4
pubmed: 8232972
Alzheimers Dement. 2022 Dec;18(12):2560-2569
pubmed: 35189039
Med Care. 2020 Sep;58(9):833-841
pubmed: 32826748
J Occup Environ Med. 2018 May;60(5):449-456
pubmed: 29135840